XML 62 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
FAIR VALUE DISCLOSURES (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
May 31, 2018
Apr. 30, 2018
Dec. 31, 2017
Feb. 28, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets         $ 5,169 $ 50,956  
Long-term Debt, Total         132,100    
Finite-Lived Intangible Assets, Gross $ 1,000   $ 284,716   288,215   $ 284,716
Inventory, Finished Goods, Gross     13,901 [1]   10,280   13,901 [1]
InventoryRawMaterials     22,139   25,766   22,139
Derivative Asset, Notional Amount         $ 74,100    
Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate         15.00%    
Inderal XL [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Finite-Lived Intangible Assets, Gross       $ 15,100      
Finite-Lived Intangible Asset, Useful Life       10 years      
Acquisition Costs Capitalized       $ 40      
Inventory, Finished Goods, Gross       5,000      
Asset Acquisition Purchase Price       $ 20,200      
Inderal XL [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate       10.00%      
InnoPran XL [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Finite-Lived Intangible Assets, Gross       $ 19,000      
Finite-Lived Intangible Asset, Useful Life       10 years      
Acquisition Costs Capitalized       $ 100      
Inventory, Finished Goods, Gross       11,600      
Asset Acquisition Purchase Price       $ 30,600      
InnoPran XL [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate       10.00%      
InnoPran XL [Member] | Cash [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets       $ 600      
InnoPran XL [Member] | Line of Credit [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets       $ 30,000      
Fair Value, Inputs, Level 1 [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Notes Payable, Fair Value Disclosure         $ 161,000    
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Interest Rate Derivative Assets, at Fair Value         300    
Equipment [Member] | Impax Laboratories, Inc. [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Finite-Lived Intangible Assets, Gross $ 58            
Finite-Lived Intangible Asset, Useful Life 5 years            
Teva Pharmaceuticals [Member] | Milestone One [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Contingent Liability Not Recognized $ 25,000            
Teva Pharmaceuticals [Member] | Milestone Two [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Contingent Liability Not Recognized 15,000            
Abbreviated New Drug Applications [Member] | Impax Laboratories, Inc. [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets 2,300            
Finite-Lived Intangible Assets, Gross $ 1,000            
Finite-Lived Intangible Asset, Useful Life 10 years            
Acquisition Costs Capitalized $ 100            
Contingent Consideration In An Asset Purchase $ 10,000            
Abbreviated New Drug Applications [Member] | Impax Laboratories, Inc. [Member] | Maximum [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate 15.00%            
Abbreviated New Drug Applications [Member] | Impax Laboratories, Inc. [Member] | Minimum [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate 10.00%            
Abbreviated New Drug Applications [Member] | IDT Australia, Limited [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets   $ 2,700          
Finite-Lived Intangible Assets, Gross   $ 2,500          
Finite-Lived Intangible Asset, Useful Life   10 years          
Acquisition Costs Capitalized   $ 18          
Abbreviated New Drug Applications [Member] | IDT Australia, Limited [Member] | Maximum [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate   15.00%          
Abbreviated New Drug Applications [Member] | IDT Australia, Limited [Member] | Minimum [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate   10.00%          
Acquired New Drug Applications [Member] | IDT Australia, Limited [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets   $ 2,700          
Finite-Lived Intangible Assets, Gross   $ 2,500          
Finite-Lived Intangible Asset, Useful Life   10 years          
Acquisition Costs Capitalized   $ 18          
InventoryRawMaterials         $ 200    
In Process Research and Development [Member] | Impax Laboratories, Inc. [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Finite-Lived Intangible Assets, Gross $ 1,300            
In Process Research and Development [Member] | Impax Laboratories, Inc. [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate 75.00%            
AstraZeneca AB and AstraZeneca UK Limited [Member] | New Drug Applications [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Payments to Acquire Intangible Assets     46,500       46,500
Finite-Lived Intangible Assets, Gross     $ 46,700       $ 46,700
Finite-Lived Intangible Asset, Useful Life     10 years       10 years
Acquisition Costs Capitalized     $ 200        
Accumulated Capitalized Interest Costs     200       $ 200
Contingent Consideration In An Asset Purchase     $ 3,000       $ 3,000
AstraZeneca AB and AstraZeneca UK Limited [Member] | New Drug Applications [Member] | Measurement Input, Discount Rate [Member]              
Fair Value Inputs, Assets, Quantitative Information              
Fair Value Input Discount Rate             10.00%
[1] Includes finished goods acquired in asset purchases (Note 12).